Much has changed since the last version was published – with the incidence of MRSA in UK hospitals falling markedly since 2008.
The update, based on clinical evidence, was also made necessary by the subsequent arrival of new anti-staphylococcal antibiotics.
The revised publication was a joint initiative of the British Society for Antimicrobial Chemotherapy (BSAC), British Infection Association (BIA), Healthcare Infection Society (HIS) and Infection Prevention Society (IPS).
BSAC and BIA alone were involved in the production of this guideline. A separate guideline updating recommendations for infection prevention and control of MRSA will be developed by HIS and IPS.